Kaplan Fox Investigates Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)
22 mai 2023 09h00 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Intercept Pharmaceuticals, Inc....